Milestone of more than 10’000 views on our policy paper challenging the ICER 12 September 2020 Mark Nuijten Lees meer
Increasing interest in our Pricing Model and Algorithm for "expensive" drugs 1 April 2018 Mark Nuijten Lees meer
Evaluation and valuation of ultra-innovative drugs: a new concept 1 August 2016 Mark Nuijten Lees meer
